Cann Group Limited (CNGGF)

Market Cap	6.39M
Revenue (ttm)	9.60M
Net Income (ttm)	-29.46M
Shares Out	n/a
EPS (ttm)	-0.06
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	500
Average Volume	2,327
Open	0.0065
Previous Close	n/a
Day's Range	0.0065 - 0.0065
52-Week Range	0.0001 - 0.0386
Beta	1.07
RSI	54.27
Earnings Date	Aug 28, 2025

About Cann Group

Cann Group Limited, together with its subsidiaries, engages in the breeding, cultivating, manufacturing, and selling medicinal cannabis in Australia and Europe. It also licenses to undertake research and to cultivate cannabis for human medicinal and research purposes. The company was founded in 2014 and is based in Port Melbourne, Australia.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2014
• Country: Australia
• Stock Exchange: OTCMKTS
• Ticker Symbol: CNGGF

Financial Performance

In 2024, Cann Group's revenue was 18.36 million, a decrease of -11.03% compared to the previous year's 20.63 million. Losses were -51.24 million, 51.6% more than in 2023.

Financial numbers in AUD